| Back to News |
|
LONGVIDA® Optimized Curcumin
|
 |
|
May 7th 2012 - Longvida Optimized Curcumin, based on patent pending discoveries from UCLA is a revolutionary new ingredient for supporting healthy brain aging based on SLCP Technology™. Longvida is the result of over ten years and hundreds of formulas tested in live bioavailability, efficacy and safety models. Longvida has blazed new paths in brain research benefiting more than 10 cognitive pathways.
The secret to true bioavailability is in the ability to meet ALL three requirements: solubility, permeability, and stability. Solid Lipid Curcumin Particle technology(SLCP) is responsible for the bioavailability breakthroughs of Longvida. It is a patent-pending, multi-step process that preserves and protects curcumin from the harsh environment of the stomach promoting rapid absorption into the bloodstream and target tissues. Half-life is the time at which half of the blood concentration is cleared from the body. Longvida is one of the only curcumin dosage forms to show stability of free curcumin in the bloodstream meaning extended release with just a single small daily dose. “There is no evidence that glucuronidated curcumin will cross the blood-brain barrier and in fact, all available evidence suggests that it will be free curcumin that will have the most efficacy,” says Dr. Greg Cole Ph.D., Professor of Medicine and Neurology at UCLA. |
|
|
Further Resources: www.longvida.com |
| Email this to a friend |
